title: Update: NCCN non-small cell lung cancer clinical practice guidelines.
authors.affiliation: The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Bunting/Blaustein Cancer Research Building, 1650 Orleans Street, Room G88, Baltimore, MD 21231-1000, USA. ettinda@jhmi.edu
authors.forename: David S
authors.initials: DS
authors.lastname: Ettinger
authors.forename: Mark G
authors.initials: MG
authors.lastname: Kris
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002289:Carcinoma, Non-Small-Cell Lung / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000473:pathology*; D017024:Chemotherapy, Adjuvant; D000077156:Gefitinib; D006801:Humans; D008175:Lung Neoplasms / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000556:secondary; D061206:Neoplasm Micrometastasis; D009367:Neoplasm Staging; D049268:Positron-Emission Tomography; D017410:Practice Guidelines as Topic; D011799:Quinazolines / Q000627:therapeutic use*
chemical_list: D000970:Antineoplastic Agents; D011799:Quinazolines; D000077156:Gefitinib